BOSTON--(BUSINESS WIRE)--Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds (LSE: ALM) and Bristol-Myers Squibb Company (NYSE: BMY), today announced that it formed a strategic partnership with Synergy Partners R&D Solutions, LLC. Synergy Partners, co-founded by Catherine D. Strader, Ph.D. and James S. MacDonald, Ph.D., comprises a network of over 20 well-respected experts that collectively have taken more than 100 drugs from discovery through development. Their team of scientists offers expertise in areas such as disease biology, medicinal chemistry, process chemistry, toxicology, pharmacology and drug safety, and have proven track records at many of the world’s leading biopharmaceutical companies, including Bristol-Myers Squibb, Merck & Co., AstraZeneca, Pfizer Inc., Johnson & Johnson and Eli Lilly & Co.
Help employers find you! Check out all the jobs and post your resume.
